中文簡(jiǎn)介

信號(hào)轉(zhuǎn)導(dǎo)與靶向治療(ISSN 2059-3635 (online)， ISSN 2095-9907 (print)， CN 51-1758/R)是一份開放獲取的期刊，旨在及時(shí)發(fā)表與信號(hào)轉(zhuǎn)導(dǎo)和靶向治療相關(guān)的基礎(chǔ)科學(xué)和臨床研究的最新發(fā)現(xiàn)和進(jìn)展。它將包括對(duì)主要人類疾病的研究，如癌癥、自身免疫性疾病等。

　　英文簡(jiǎn)介

Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is an open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, such as cancer, autoimmune disorders and others.

　　近年期刊自引率趨勢(shì)圖

　　JCR分區(qū)

JCR分區(qū)等級(jí)	JCR所屬學(xué)科	分區(qū)	影響因子
Q1	CELL BIOLOGY	Q1	38.104
	BIOCHEMISTRY & MOLECULAR BIOLOGY	Q1

　　近年期刊影響因子趨勢(shì)圖

　　CiteScore數(shù)值

CiteScore	SJR	SNIP	學(xué)科類別	分區(qū)	排名	百分位
18.40	5.157	3.979	大類：Biochemistry, Genetics and Molecular Biology 小類：Genetics	Q1	11 / 335	96%
			大類：Biochemistry, Genetics and Molecular Biology 小類：Cancer Research	Q1	13 / 210	94%